文献速递临床试验与 GCP流行病学与生物统计

通过优先考虑定性与定量临床试验证据来变革医疗:评估老龄化、社区与健康研究单位的老年人社区合作项目(ACHRU-CPP)

Transforming healthcare by prioritizing qualitative and quantitative clinical trial evidence: evaluating the Aging, Community and Health Research Unit's Community Partnership Program for Older Adults (ACHRU-CPP).
PubMed 文献 · Trials · 2025-05-13

本研究旨在检验一项针对老年人的复杂整合照护干预的有效性与实施情况,采用多站点实用型混合II型效果-实施随机对照试验,同时收集定量与定性数据。当前试验的主要和次要结局均未显示统计学显著效应,但实施评价一致发现患者、提供者和医疗系统感知到获益。定性证据有助于理解可能解释缺乏治疗效应的情境因素(如COVID-19),并支持该干预的未来实施。

要点

  • 当前随机对照试验的主要和次要结局均未显示统计学显著效应。
  • 实施评价一致发现患者、提供者和医疗系统感知到干预获益。
  • 定性证据有助于理解缺乏治疗效应的情境因素(如COVID-19)。

核心结论

  • 当前随机对照试验的主要和次要结局均未显示统计学显著效应,但实施评价一致发现患者、提供者和医疗系统感知到干预获益。
  • 定性证据对于理解可能解释缺乏治疗效应的情境因素(如COVID-19)、克服参与者参与和干预实施中挑战的策略,以及与干预高度一致并支持其未来实施的近期政策/实践环境变化至关重要。
  • 利益相关者鼓励继续进行可扩展性评估,以在先前研究、类似干预的更广泛文献和不断变化的政策背景下考虑当前试验的证据。

研究设计与样本

  • 多站点实用型混合II型效果-实施随机对照试验(RCT),同时收集定量与定性数据以评估有效性和实施情况。
  • 试验注册号:clinicaltrials.gov NCT03664583,注册日期:2018年9月10日。

主要发现

  • 当前随机对照试验的主要和次要结局均未显示统计学显著效应。
  • 实施评价一致发现患者、提供者和医疗系统感知到干预获益。
  • 定性证据有助于理解可能解释缺乏治疗效应的情境因素(如COVID-19)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to test the effectiveness and implementation of a complex integrated care intervention for older adults. We collected both quantitative and qualitative data, which is recommended in evaluating complex interventions to gain a comprehensive understanding of key success factors. Often, congruence is sought and considered desirable when integrating the findings from both data types. However, data are not always congruent, nor is it suboptimal when incongruence occurs, as we illustrate in this case study. We present the divergent findings from a large community-based implementation-effectiveness hybrid type II trial, and how the struggle to reconcile incongruent results yielded rich insights informing the next steps for translational research on the intervention being tested. METHODS: Previous foundational research, including a pilot study and randomized controlled trial (RCT), showed promising results and supported proceeding with a multi-site pragmatic hybrid type II effectiveness-implementation RCT. This recent RCT was undertaken and quantitative and qualitative data were collected to inform the effectiveness and implementation evaluation. To synthesize the findings and guide integration of this large body of evidence, we developed a conceptual model which combined two existing frameworks: the Consolidated Framework for Implementation Research and Quintuple Aim. We used this model to identify the evidence and relate it to relevant implementation and intervention determinants/outcomes. We then synthesized the evidence to distall the main messages regarding the future of the intervention, which involved reconciling apparently discrepant findings from the quantitative and qualitative approaches. RESULTS: The current RCT showed no statistically significant effect for participants for the primary (or secondary) outcomes yet the implementation evaluation consistently found perceived benefits of the intervention for patients, providers, and the healthcare system. Qualitative evidence was critical in understanding contextual factors potentially responsible for the absence of a treatment effect (e.g., COVID-19), strategies to overcome challenges experienced in participant engagement and intervention delivery, and recent policy/practice setting changes which showed strong alignment with the intervention and supported its future implementation. CONCLUSIONS: With the goal of the hybrid type II effectiveness and implementation study in mind, stakeholders encouraged proceeding with a scalability assessment to consider the evidence from the current trial within the context of our prior research, the broader literature for similar interventions, and the ever-changing policy context. TRIAL REGISTRATION: clinicaltrials.gov NCT03664583. Registration date: September 10, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fisher K, Carusone SC, Ganann R, et al. Transforming healthcare by prioritizing qualitative and quantitative clinical trial evidence: evaluating the Aging, Community and Health Research Unit's Community Partnership Program for Older Adults (ACHRU-CPP). Trials. 2025. PMID: 40361198. doi:10.1186/s13063-025-08839-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。